Therapeutic potential of ADAM10 modulation in Alzheimer’s disease: a review of the current evidence
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Therapeutic potential of ADAM10 modulation in Alzheimer’s disease: a review of the current evidence ; volume:21 ; number:1 ; day:14 ; month:3 ; year:2023 ; pages:1-12 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (14.3.2023), 1-12, 12.2023
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Khezri, Mohammad Rafi
Mohebalizadeh, Mehdi
Ghasemnejad-Berenji, Morteza
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01072-w
- URN
-
urn:nbn:de:101:1-2023080421082986131658
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khezri, Mohammad Rafi
- Mohebalizadeh, Mehdi
- Ghasemnejad-Berenji, Morteza
- SpringerLink (Online service)
Other Objects (12)
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Alzheimer disease : therapeutic strategies
Current state of Alzheimer’s fluid biomarkers
Fluid biomarkers in Alzheimer’s disease – current concepts
Rho GTPases as therapeutic targets in Alzheimer’s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Therapeutic implications of necroptosis activation in Alzheimer´s disease
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Alzheimer disease : therapeutic strategies
Current state of Alzheimer’s fluid biomarkers
Fluid biomarkers in Alzheimer’s disease – current concepts
Rho GTPases as therapeutic targets in Alzheimer’s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Therapeutic implications of necroptosis activation in Alzheimer´s disease
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Alzheimer disease : therapeutic strategies
Current state of Alzheimer’s fluid biomarkers
Fluid biomarkers in Alzheimer’s disease – current concepts
Rho GTPases as therapeutic targets in Alzheimer’s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Therapeutic implications of necroptosis activation in Alzheimer´s disease
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease